Generalized epilepsy with febrile seizures plus: genes and variants
Explore variant evidence for Generalized epilepsy with febrile seizures plus across 5 analyzed proteins (SCN1A, SCN9A, HCN1, SCN1B, GABRG2). Linked ClinVar records include 101 pathogenic or likely pathogenic variants, 1,205 variants of uncertain significance and 109 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Generalized epilepsy with febrile seizures plus
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
76 ClinVar pathogenic / likely pathogenic and 86 uncertain variants in SCN1A have source records linked to Generalized epilepsy with febrile seizures plus. Association strength is not clinical gene validity.
SCN9A: Sodium channel protein type 9 subunit alpha
The protein forms Nav1.7, a voltage-gated sodium channel that amplifies electrical signals in peripheral sensory neurons. Changes in Nav1.7 activity can produce either excessive pain or congenital insensitivity to pain, making SCN9A central to pain biology.
14 ClinVar pathogenic / likely pathogenic and 1,193 uncertain variants in SCN9A have source records linked to Generalized epilepsy with febrile seizures plus. Association strength is not clinical gene validity.
HCN1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
The protein forms a hyperpolarization-activated channel that conducts both potassium and sodium ions. It contributes to pacemaker currents and the neuronal I(h) current that shapes excitability, and HCN1 variants are associated with developmental epilepsy syndromes.
10 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in HCN1 have source records linked to Generalized epilepsy with febrile seizures plus. Association strength is not clinical gene validity.
SCN1B: Sodium channel regulatory subunit beta-1
The beta-1 subunit of voltage-gated sodium channels, which regulates channel activity and cell adhesion. Pathogenic variants cause several forms of epilepsy, while associations with cardiac arrhythmias have also been reported.
1 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in SCN1B have source records linked to Generalized epilepsy with febrile seizures plus. Association strength is not clinical gene validity.
GABRG2: Gamma-aminobutyric acid receptor subunit gamma-2
The gene product supplies the gamma-2 subunit of synaptic GABA-A receptors, which are pentameric chloride channels activated by the inhibitory neurotransmitter GABA. The subunit helps receptor assembly and localization at neuronal membranes, and GABRG2 variants are associated with several epilepsy syndromes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GABRG2 have source records linked to Generalized epilepsy with febrile seizures plus. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RELN.
ClinVar pathogenic and likely pathogenic variants linked to Generalized epilepsy with febrile seizures plus
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN1A V1637A | 1637 | IV | Pathogenic / likely pathogenic (★★★) |
| SCN1A A420V | 420 | I | Pathogenic / likely pathogenic (★★★) |
| SCN1A T1210M | 1210 | III | Pathogenic / likely pathogenic (★★★) |
| SCN1A S570N | 570 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| SCN9A V1310F | 1310 | III | Pathogenic / likely pathogenic (★★) |
| SCN9A R907W | 907 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A I1472T | 1472 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A P281S | 281 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A M145T | 145 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A R377Q | 377 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A Y790F | 790 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R862L | 862 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A M956T | 956 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A A1429V | 1429 | III | Pathogenic / likely pathogenic (★★) |
| SCN9A R907Q | 907 | II | Pathogenic / likely pathogenic (★★) |
| HCN1 S100F | 100 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A M934R | 934 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A D936Y | 936 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R946C | 946 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A M976T | 976 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A V983G | 983 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A I1638N | 1638 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A A1669T | 1669 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A A1783T | 1783 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A W1284R | 1284 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A P1519T | 1519 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A R1861W | 1861 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN9A V400M | 400 | I | Pathogenic / likely pathogenic (★★) |
| SCN9A I859T | 859 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A L869H | 869 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A Y84C | 84 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A I91T | 91 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A R101Q | 101 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A L117P | 117 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A A121P | 121 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A H127Y | 127 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G210D | 210 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A L224S | 224 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G271S | 271 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G329V | 329 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A L390P | 390 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A M785V | 785 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R865Q | 865 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A C927R | 927 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A S940Y | 940 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A F945L | 945 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A M960T | 960 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A E1221K | 1221 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A G1275D | 1275 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A L1340P | 1340 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A L1352P | 1352 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A G1371D | 1371 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A W1434R | 1434 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A A1441V | 1441 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A A1641T | 1641 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A I1922T | 1922 | IQ | Pathogenic / likely pathogenic (★★) |
| SCN1A Q1923H | 1923 | IQ | Pathogenic / likely pathogenic (★★) |
| SCN1B R85H | 85 | Ig-like C2-type | Pathogenic / likely pathogenic (★★) |
| SCN1A I1545V | 1545 | IV | Pathogenic / likely pathogenic (★★) |
| SCN9A I1472N | 1472 | III | Pathogenic / likely pathogenic (★) |
Showing 60 of 101.
Which prediction tools work for Generalized epilepsy with febrile seizures plus
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- ESM1b (LLR): 93 out of 100
- AlphaGenome (regulatory): 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 89 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 82 out of 100
- CADD: 80 out of 100
- phyloP: 66 out of 100
- AlphaGenome (splicing): 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Early-infantile DEE also has ClinVar records linked to SCN1A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (422 pathogenic / likely pathogenic).
- Severe myoclonic epilepsy in infancy also has ClinVar records linked to SCN1A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (213 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (46 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to SCN1A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (20 pathogenic / likely pathogenic).
- Autosomal dominant epilepsy also has ClinVar records linked to SCN1A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (4 pathogenic / likely pathogenic).
- Primary erythermalgia also has ClinVar records linked to SCN9A variants; they fall mostly in different places as the Generalized epilepsy with febrile seizures plus variants (6 pathogenic / likely pathogenic).
- Paroxysmal extreme pain disorder also has ClinVar records linked to SCN9A variants; they fall partly in the same places as the Generalized epilepsy with febrile seizures plus variants (4 pathogenic / likely pathogenic).
- Early-infantile DEE also has ClinVar records linked to HCN1 variants; they fall mostly in different places as the Generalized epilepsy with febrile seizures plus variants (14 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to HCN1 variants; they fall mostly in different places as the Generalized epilepsy with febrile seizures plus variants (8 pathogenic / likely pathogenic).
- Brugada syndrome also has ClinVar records linked to SCN1B variants; they fall mostly in different places as the Generalized epilepsy with febrile seizures plus variants (4 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1B variants; they fall mostly in different places as the Generalized epilepsy with febrile seizures plus variants (3 pathogenic / likely pathogenic).
Diseases related to Generalized epilepsy with febrile seizures plus
- Developmental and epileptic encephalopathy, also linked to GABRG2, HCN1, SCN1A and SCN1B
- Genetic developmental and epileptic encephalopathy, also linked to GABRG2, HCN1, SCN1A and SCN1B
- Epilepsy, also linked to GABRG2, SCN1A and SCN9A
- Migraine, also linked to GABRG2, SCN1A and SCN9A
- Lennox-Gastaut syndrome, also linked to GABRG2, SCN1A and SCN9A
- Early-infantile DEE, also linked to HCN1 and SCN1A
- Severe myoclonic epilepsy in infancy, also linked to HCN1 and SCN1A
- Amyotrophic lateral sclerosis, also linked to SCN1A and SCN9A
- Cardiac arrhythmia, also linked to SCN1A and SCN9A
- Familial febrile seizures, also linked to GABRG2 and SCN1A
- Focal epilepsy, also linked to SCN1A and SCN9A
- Familial hemiplegic migraine, also linked to SCN1A
Frequently asked questions
Which genes have records linked to Generalized epilepsy with febrile seizures plus?
This view contains 5 analyzed proteins: SCN1A, SCN9A, HCN1, SCN1B, GABRG2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 101 pathogenic or likely pathogenic variants, 1,205 variants of uncertain significance and 109 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,474 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center